herceptin 600 mg/5 ml rastvor za injekciju
roche d.o.o.roche ltd. - trastuzumab - rastvor za injekciju - 600 mg/5 ml - 1 bočica sa 5 ml rastvora za injekciju sadrži: 600 mg trastuzumaba
nolvadex 10 mg filmom obložene tablete
astrazeneca d.o.o., radnička cesta 80, zagreb, hrvatska - tamoksifencitrat - filmom obložena tableta - 10 mg - urbroj: jedna filmom obložena tableta sadrži 10,0 mg tamoksifena u obliku tamoksifencitrata
phesgo
roche registration gmbh - pertuzumab, trastuzumab - neoplazme dojki - antineoplastična sredstva - early breast cancer (ebc)phesgo is indicated for use in combination with chemotherapy in:the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrencethe adjuvant treatment of adult patients with her2-positive early breast cancer at high risk of recurrencemetastatic breast cancer (mbc)phesgo is indicated for use in combination with docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.
phesgo 600 mg/10 ml+ 600 mg/10 ml otopina za injekciju
roche d.o.o.roche ltd. - pertuzumab, trastuzumab - otopina za injekciju - 600 mg/10 ml+ 600 mg/10 ml - 1 bočica sa 10 ml otopine za injekciju sadrži: 600 mg pertuzumaba 600 mg trastuzumaba
phesgo 1200 mg/15 ml+ 600 mg/15 ml otopina za injekciju
roche d.o.o.roche ltd. - pertuzumab, trastuzumab - otopina za injekciju - 1200 mg/15 ml+ 600 mg/15 ml - 1 bočica sa 15 ml otopine za injekciju sadrži: 1200 mg pertuzumaba 600 mg trastuzumaba